Glucosylceramide modulates membrane traffic along the endocytic pathway
Glycosphingolipids are endocytosed and targeted to the Golgi apparatus, but are mistargeted to lysosomes in numerous sphingolipidoses. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Gaucher disease is a heredita...
Main Authors: | Dan J. Sillence, Vishwajeet Puri, David L. Marks, Terry D. Butters, Raymond A. Dwek, Richard E. Pagano, Frances M. Platt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2002-11-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520327589 |
Similar Items
-
Glucosylceramide modulates membrane traffic along the endocytic pathway.
by: Sillence, D, et al.
Published: (2002) -
Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
by: Natsuki Kita, et al.
Published: (2024-03-01) -
Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain
by: Scott D. Larsen, et al.
Published: (2012-02-01) -
Protein Sorting in Plasmodium Falciparum
by: D.C. Ghislaine Mayer
Published: (2021-09-01) -
The Cellular and Chemical Biology of Endocytic Trafficking and Intracellular Delivery—The GL–Lect Hypothesis
by: Ludger Johannes
Published: (2021-05-01)